Murakawa Yuji, Yamane Teiichi, Goya Masahiko, Inoue Koichi, Naito Shigeto, Kumagai Koichiro, Miyauchi Yasushi, Morita Norishige, Nogami Akihiko, Shoda Morio, Okumura Ken, Hirao Kenzo
Fourth Department of Internal Medicine Teikyo University School of Medicine Kawasaki Japan.
The Department of Cardiology The Jikei University School of Medicine Tokyo Japan.
J Arrhythm. 2018 Jul 6;34(4):435-440. doi: 10.1002/joa3.12081. eCollection 2018 Aug.
In expectation of better outcome of catheter ablation of atrial fibrillation (AF), several strategies of extra-PV (pulmonary vein) substrate modification have been utilized. We assessed whether substrate modification or ablation of extra-PV source is a predictor of complications.
Japanese Heart Rhythm Society requested electrophysiology centers to register the data of patients who underwent AF ablation.
The data of 10 795 AF ablation cases (age; 63.8 ± 10.6 years) treated during 2011-2016 were registered. Pericardial effusion (n = 105), massive bleeding (n = 108), stroke (n = 6), atrial-esophageal fistula (n = 2), and other 114 complications occurred in 323 patients (3.0%). Univariate analysis revealed that age ≧ 65 years, female gender, heart failure, CHA2DS2-VASc≧3, hemodialysis, deep sedation, and complex fractionated atrial electrogram (CFAE)-guided ablation ([+] vs [-] = 4.3% vs 2.8%, = .005) were related with the higher incidence of complications. Redo session, 3-D imaging system ([+] vs [-]: 4.4% vs 2.9%, = .017), and periprocedural dabigatran were related with the lower incidence of complications. None of the linear ablation of the left atrium, ganglionated plexi ablation, and superior vena cava ablation affected the incidence of complications. Multiple logistic regression analysis showed that in addition to 3-D imaging system, age ≧ 65 years, redo session, and deep sedation, CFAE ablation was an independent predictor of the risk of complications (OR 1.78, = .001). Specifically, implantation of a permanent pacemaker due to emerging sinus node dysfunction was frequent after CFAE ablation (CFAE [+] vs [-] = 4/1047 vs 2/9748, < .001).
Among extra-PV ablation strategies, CFAE-guided ablation is a predictor of ablation-related complications.
为了期望获得更好的房颤导管消融治疗效果,已采用了几种肺静脉外基质改良策略。我们评估了基质改良或肺静脉外起源点消融是否为并发症的预测因素。
日本心律协会要求电生理中心登记接受房颤消融治疗患者的数据。
登记了2011年至2016年期间治疗的10795例房颤消融病例(年龄63.8±10.6岁)的数据。323例患者(3.0%)发生心包积液(n = 105)、大出血(n = 108)、卒中(n = 6)、心房食管瘘(n = 2)以及其他114例并发症。单因素分析显示,年龄≥65岁、女性、心力衰竭、CHA2DS2-VASc≥3、血液透析、深度镇静以及复杂碎裂心房电图(CFAE)指导下的消融([+]组与[-]组分别为4.3%对2.8%,P = 0.005)与较高的并发症发生率相关。再次手术、三维成像系统([+]组与[-]组:4.4%对2.9%,P = 0.017)以及围手术期使用达比加群与较低的并发症发生率相关。左心房线性消融、神经节丛消融以及上腔静脉消融均未影响并发症发生率。多因素logistic回归分析显示,除三维成像系统外,年龄≥65岁、再次手术、深度镇静以及CFAE消融是并发症风险的独立预测因素(OR 1.78,P = 0.001)。具体而言,CFAE消融后因新出现的窦房结功能障碍而植入永久起搏器的情况很常见(CFAE[+]组与[-]组分别为4/1047对2/9748,P < 0.001)。
在肺静脉外消融策略中,CFAE指导下的消融是消融相关并发症的预测因素。